Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Remedium Lifecare Ltd has informed the BSE that its trading window for insiders will remain closed from July 1, 2025 until 48 hours after the declaration of unaudited financial results (standalone and consolidated) for Q1 FY26 ending June 30, 2025. This is done in compliance with the company's internal code under SEBI's Insider Trading Regulations, 2015. The date of the board meeting to approve the quarterly results will be communicated separately. The intimation is signed by Adarsh Munjal, Whole Time Director.
This is a routine regulatory compliance filing with no direct impact on stock price. It simply signals that Q1 FY26 results are approaching and insiders are barred from trading until the results are publicly disclosed.